Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 23, 2023
SIRT6 pharmacological inhibition delays skin cancer progression in the squamous cell carcinomaElena Abbotto, Caterina Miro, Francesco Piacente, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Structure-Based Identification and Biological Characterization of New NAPRT InhibitorsJorge Franco, Francesco Piacente, Melanie Walter, et al.
Journal of Medicinal Chemistry|August 15, 2014
A new avenue toward androgen receptor pan-antagonists: C2 sterically hindered substitution of hydroxy-propanamidesAndrea Guerrini, Anna Tesei, Claudia Ferroni, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug DiscoveryMoustafa S Ghanem, Irene Caffa, Alberto Del Rio, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 8, 2017
Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse modelGiovanna Sociali, Mirko Magnone, Silvia Ravera, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2021
Evaluation of two <i>in vitro</i> assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cellsMyriam Lemmens, Benoit Fischer, Michael Zogg, et al.
JCI Insight|March 15, 2017
Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrationsChristine Guntermann, Alessandro Piaia, Marie-Laure Hamel, et al.
Pharmacogenomics|April 6, 2013
Genes involved in hemorrhagic transformations that follow recombinant t-PA treatment in stroke patientsIsrael Fernandez-Cadenas, Alberto Del Rio-Espinola, Sophie Domingues-Montanari, et al.
Pageof 9